These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27326818)

  • 1. Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats.
    Sivasinprasasn S; Sa-Nguanmoo P; Pongkan W; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    Menopause; 2016 Aug; 23(8):894-902. PubMed ID: 27326818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.
    Tanajak P; Pintana H; Siri-Angkul N; Khamseekaew J; Apaijai N; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2017 Feb; 232(2):189-204. PubMed ID: 27875248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction.
    Apaijai N; Inthachai T; Lekawanvijit S; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2016 Jun; 229(3):245-58. PubMed ID: 27044778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
    Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
    Br J Pharmacol; 2013 Jul; 169(5):1048-57. PubMed ID: 23488656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats.
    Apaijai N; Chinda K; Palee S; Chattipakorn S; Chattipakorn N
    PLoS One; 2014; 9(7):e102374. PubMed ID: 25036861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats.
    Pongkan W; Pintana H; Jaiwongkam T; Kredphoo S; Sivasinprasasn S; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2016 Oct; 231(1):81-95. PubMed ID: 27543302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats.
    Sivasinprasasn S; Tanajak P; Pongkan W; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    Sci Rep; 2017 Mar; 7():44306. PubMed ID: 28281660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance.
    Ittichaicharoen J; Apaijai N; Tanajak P; Sa-Nguanmoo P; Chattipakorn N; Chattipakorn S
    Arch Oral Biol; 2018 Jan; 85():148-153. PubMed ID: 29073562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
    Tanajak P; Sa-Nguanmoo P; Apaijai N; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28391633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
    Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
    Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.
    Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
    Endocrinology; 2012 Aug; 153(8):3878-85. PubMed ID: 22621958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase 4 inhibitor improves brain insulin sensitivity, but fails to prevent cognitive impairment in orchiectomy obese rats.
    Pintana H; Pongkan W; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    J Endocrinol; 2015 Aug; 226(2):M1-M11. PubMed ID: 26016746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Toxicol Appl Pharmacol; 2017 Oct; 333():43-50. PubMed ID: 28807765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Wang X; Liang G; Li X; Jiang C; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Biomed Pharmacother; 2018 Jan; 97():1663-1672. PubMed ID: 29793329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats.
    Pratchayasakul W; Sivasinprasasn S; Sa-Nguanmoo P; Proctor C; Kerdphoo S; Chattipakorn N; Chattipakorn SC
    Menopause; 2017 Jul; 24(7):850-858. PubMed ID: 28291027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption.
    Pipatpiboon N; Pintana H; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Eur J Neurosci; 2013 Mar; 37(5):839-49. PubMed ID: 23240760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen deprivation aggravates cardiometabolic dysfunction in obese-insulin resistant rats through the impairment of cardiac mitochondrial dynamics.
    Minta W; Palee S; Mantor D; Sutham W; Jaiwongkam T; Kerdphoo S; Pratchayasakul W; Kumfu S; Chattipakorn SC; Chattipakorn N
    Exp Gerontol; 2018 Mar; 103():107-114. PubMed ID: 29331535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.
    Sivasinprasasn S; Sa-Nguanmoo P; Pratchayasakul W; Kumfu S; Chattipakorn SC; Chattipakorn N
    Age (Dordr); 2015; 37(2):28. PubMed ID: 25791519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats.
    Pintana H; Apaijai N; Chattipakorn N; Chattipakorn SC
    J Endocrinol; 2013 Jul; 218(1):1-11. PubMed ID: 23591914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovariectomy and obesity have equal impact in causing mitochondrial dysfunction and impaired skeletal muscle contraction in rats.
    Sutham W; Sripetchwandee J; Minta W; Mantor D; Pattanakuhar S; Palee S; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Menopause; 2018 Dec; 25(12):1448-1458. PubMed ID: 29994976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.